Clinical trial failure is both inevitable and multi-factorial. Translational research often reaches dead ends as the complexity of human biology and incomplete understanding of disease processes are laid bare. New therapeutic advances are therefore incredibly hard-won, and usually accompanied by a slice of good fortune as scientific leaps of faith are proven correct.
As many as 86% of clinical trials do not reach recruitment targets within their specified time periods, as actual enrollment times typically double the planned estimates.
This article highlights best practices including enhancing recruitment efforts with real-world data and specifies how to project timelines with greater accuracy.
Read the source article at In Vivo